retatrutide drug retatrutide clinical trials (“reta”) is an experimental weight-loss currently in Phase 3 trials. It's a once-weekly injection similar to Ozempic and Mounjaro—but more powerful. The reason comes down to how it works lilly retatrutide trial The drug

MeAgain stores progress photos as part of Journey Cards alongside the rest of the routine

Endocrinology 147 , 37273736

But these aren't approved medical uses

This timeframe generally corresponds with the body's adaptation period to the medication and its metabolic effects

Side Effect Comparison All three compounds produce the same underlying GI side-effect pattern nausea, diarrhea, vomiting, constipation because they all slow gastric emptying and activate brainstem pathways that regulate nausea

Additionally, both semaglutide and tirzepatide showed promise in improving metabolic dysfunction-associated steatotic liver disease (MASLD), mitigating systemic inflammation, and contributing to improvements in liver-related outcomes, including steatosis resolution and fibrosis-related endpoints, in clinical trials